Search

Benny Quoc Tieu

Supervisory Patent Examiner (ID: 2443, Phone: (571)272-7490 , Office: P/2674 )

Most Active Art Unit
2642
Art Unit(s)
2614, 2642, 2625, 2742, 2674, 2682
Total Applications
759
Issued Applications
578
Pending Applications
87
Abandoned Applications
103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16883863 [patent_doc_number] => 20210170058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => MODIFIED ANTIBODY AND RADIOACTIVE METAL-LABELLED ANTIBODY [patent_app_type] => utility [patent_app_number] => 17/047859 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10865 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/047859
Modified antibody and radioactive metal-labelled antibody Apr 14, 2019 Issued
Array ( [id] => 16824239 [patent_doc_number] => 20210139532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => PEPTIDE SYNTHESIS METHOD [patent_app_type] => utility [patent_app_number] => 17/046682 [patent_app_country] => US [patent_app_date] => 2019-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046682 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/046682
Peptide synthesis method Apr 12, 2019 Issued
Array ( [id] => 16817010 [patent_doc_number] => 11001817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-11 [patent_title] => Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs) [patent_app_type] => utility [patent_app_number] => 16/382927 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29785 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382927 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382927
Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs) Apr 11, 2019 Issued
Array ( [id] => 17241994 [patent_doc_number] => 20210361737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => ANTI-INFECTIVE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/046271 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -139 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046271 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/046271
Anti-infective formulations Apr 10, 2019 Issued
Array ( [id] => 16915830 [patent_doc_number] => 20210188922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => COMPOSITIONS, METHODS, AND SYSTEMS FOR ORALLY ADMINISTRABLE AFFINITY-BASED PROTEIN [patent_app_type] => utility [patent_app_number] => 17/041780 [patent_app_country] => US [patent_app_date] => 2019-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041780 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/041780
Compositions, methods, and systems for orally administrable affinity-based protein Mar 24, 2019 Issued
Array ( [id] => 16539407 [patent_doc_number] => 20200405820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => PARATHYROID HORMONE POLYPEPTIDE CONJUGATES AND METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 16/980944 [patent_app_country] => US [patent_app_date] => 2019-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980944 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/980944
Parathyroid hormone polypeptide conjugates and methods of their use Mar 14, 2019 Issued
Array ( [id] => 16605945 [patent_doc_number] => 10906937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Peptides and compositions comprising same and uses thereof in the treatment of diseases [patent_app_type] => utility [patent_app_number] => 16/299206 [patent_app_country] => US [patent_app_date] => 2019-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 12864 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299206 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/299206
Peptides and compositions comprising same and uses thereof in the treatment of diseases Mar 11, 2019 Issued
Array ( [id] => 16621506 [patent_doc_number] => 20210040159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => CPG AMPHIPHILES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/977185 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977185 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/977185
CpG amphiphiles and uses thereof Feb 28, 2019 Issued
Array ( [id] => 19456322 [patent_doc_number] => 12096785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-24 [patent_title] => Lipid emulsion nutritional product [patent_app_type] => utility [patent_app_number] => 16/971055 [patent_app_country] => US [patent_app_date] => 2019-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 6392 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971055 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971055
Lipid emulsion nutritional product Feb 18, 2019 Issued
Array ( [id] => 14534525 [patent_doc_number] => 20190202884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => MODIFIED GLUCAGON MOLECULES [patent_app_type] => utility [patent_app_number] => 16/278851 [patent_app_country] => US [patent_app_date] => 2019-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16278851 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/278851
Modified glucagon molecules Feb 18, 2019 Issued
Array ( [id] => 14744019 [patent_doc_number] => 20190255183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => CNP PRODRUGS [patent_app_type] => utility [patent_app_number] => 16/269097 [patent_app_country] => US [patent_app_date] => 2019-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38261 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269097 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/269097
CNP PRODRUGS Feb 5, 2019 Abandoned
Array ( [id] => 16892077 [patent_doc_number] => 11033604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Reagents and methods for treating bacterial infection [patent_app_type] => utility [patent_app_number] => 16/258505 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12586 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16258505 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/258505
Reagents and methods for treating bacterial infection Jan 24, 2019 Issued
Array ( [id] => 14566911 [patent_doc_number] => 20190211062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Modified Proteins and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 16/250213 [patent_app_country] => US [patent_app_date] => 2019-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16250213 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/250213
Modified proteins and methods of use thereof Jan 16, 2019 Issued
Array ( [id] => 15267421 [patent_doc_number] => 20190382444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => Zinc-binder Based EBNA1-Specific Compounds [patent_app_type] => utility [patent_app_number] => 16/249987 [patent_app_country] => US [patent_app_date] => 2019-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16249987 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/249987
Zinc-binder based EBNA1-specific compounds Jan 16, 2019 Issued
Array ( [id] => 16168220 [patent_doc_number] => 10709760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Treatment of chronic ulcers [patent_app_type] => utility [patent_app_number] => 16/245642 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6797 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245642 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/245642
Treatment of chronic ulcers Jan 10, 2019 Issued
Array ( [id] => 17844911 [patent_doc_number] => 11434263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Stabilized polypeptides and uses thereof [patent_app_type] => utility [patent_app_number] => 16/955557 [patent_app_country] => US [patent_app_date] => 2019-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 11603 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955557 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955557
Stabilized polypeptides and uses thereof Jan 3, 2019 Issued
Array ( [id] => 16686810 [patent_doc_number] => 20210069285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER WITH GLYCOMIMETIC PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/960267 [patent_app_country] => US [patent_app_date] => 2019-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960267 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/960267
Compositions and methods of treating cancer with glycomimetic peptides Jan 2, 2019 Issued
Array ( [id] => 14403833 [patent_doc_number] => 20190167760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5 [patent_app_type] => utility [patent_app_number] => 16/228181 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -89 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228181 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/228181
Polypeptides binding to human complement C5 Dec 19, 2018 Issued
Array ( [id] => 18070605 [patent_doc_number] => 11529421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-20 [patent_title] => Modified globin proteins [patent_app_type] => utility [patent_app_number] => 15/733287 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 20692 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733287 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/733287
Modified globin proteins Dec 18, 2018 Issued
Array ( [id] => 14277177 [patent_doc_number] => 20190135873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISEASES BY INHIBITING EXOSOME RELEASE [patent_app_type] => utility [patent_app_number] => 16/226283 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23977 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16226283 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/226283
Compositions and methods for treating diseases by inhibiting exosome release Dec 18, 2018 Issued
Menu